Alkhouri N, Herring R, Kabler H, Kayali Z, et al. Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial. J Hepatol 2022 Apr 16. pii: S0168-8278(22)00235.
PMID: 35439567